Deerfield Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-251,000
| Closed | -$20M | – | 103 |
|
|
2019
Q4 | $20M | Sell |
251,000
-17,100
| -6% | -$1.36M | 0.64% | 49 |
|
|
2019
Q3 | $13M | Buy |
268,100
+33,100
| +14% | +$1.61M | 0.53% | 56 |
|
|
2019
Q2 | $12.4M | Buy |
+235,000
| New | +$12.4M | 0.44% | 65 |
|
|
2017
Q1 | – | Sell |
-171,428
| Closed | -$2.48M | – | 113 |
|
|
2016
Q4 | $2.48M | Hold |
171,428
| – | – | 0.1% | 87 |
|
|
2016
Q3 | $3.95M | Sell |
171,428
-1,562,400
| -90% | -$36M | 0.18% | 66 |
|
|
2016
Q2 | $28.8M | Buy |
1,733,828
+540,017
| +45% | +$8.96M | 1.13% | 34 |
|
|
2016
Q1 | $18.9M | Buy |
1,193,811
+30,000
| +3% | +$476K | 0.81% | 44 |
|
|
2015
Q4 | $37.6M | Buy |
1,163,811
+273,191
| +31% | +$8.83M | 1.52% | 14 |
|
|
2015
Q3 | $37.5M | Buy |
+890,620
| New | +$37.5M | 1.45% | 20 |
|